Closing the Gap Between Clinical Research and Post-Market Care

Closing the Gap Between Clinical Research and Post-Market Care The end of a clinical trial typically marks a transitional period where participants stop contributing structured study data and resume care within the standard clinical setting. But the use of continuous, real-world monitoring in pharmaceutical development is beginning to change this structure, closing the gap between clinical research and post-market care.